Mirador Capital Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Mirador Capital Partners's LLY Position: Q2 2026 in Review
Mirador Capital Partners increased its Eli Lilly (LLY) stake by 7.5% in Q2 2026, buying an estimated $119K and bringing the position to 1,657 shares worth $1.99M. The position accounts for 0.24% of the portfolio, ranked #67.
Mirador Capital Partners first reported a position in LLY in Q1 2016 and has held it in 18 quarters since. The position peaked at $2.98M in Q1 2021. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Mirador Capital Partners held 1,657 shares of Eli Lilly worth $1.99M as of Q2 2026.
- Mirador Capital Partners bought 116 Eli Lilly shares in Q2 2026, an estimated $119K.
- Eli Lilly made up 0.24% of Mirador Capital Partners's portfolio in Q2 2026, its #67 holding.
- Mirador Capital Partners first reported a position in Eli Lilly in Q1 2016 and has held it in 18 quarters since.
- Mirador Capital Partners's Eli Lilly position peaked at $2.98M in Q1 2021.
- 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Mirador Capital Partners's 13F filing for Q2 2026, filed 7 Jul 2026.